Assessment of thyroglobulin expression in reproductive organs at different stages of mouse estrous cycle.
Abortion is the most prevalent complication of pregnancy. In more than half of the cases, the underlying cause of abortion is unknown. However, a variety of factors such as genetic abnormalities, structural problems, autoimmune diseases and infections have been known to cause abortion (1,2).
Among the autoimmune diseases implicated to cause abortion and infertility, thyroid autoimmunity is thought to be the most prominent one (3-7). Most patients with thyroid autoimmunity have high serum levels of anti thyroglobulin (TG) and/or antithyroid peroxidase (TPO) antibodies.
One mechanism by which these antibodies can cause infertility, abortion or congenital abnormalities in the fetus, is by direct binding to thyroid proteins vital for thyroid hormone production with consequent reduction in serum levels of thyroid hormones (8-10).
In the majority of cases, however, no abnormality of thyroid function is detected despite high levels of antithyroid antibodies. It has been shown that recurrent abortion is still 2 to 4 times more frequent in these patients compared to normal women (3,4,11). Moreover, infertile women with high levels of peroxidase autoantibodies tend to have more abortions after receiving IVF treatment for their infertility (7,12). Indeed, maternal thyroid peroxidase antibodies during pregnancy are associated with impaired child development(13).
Although there are some speculations as to how thyroid autoantibodies are linked to abortion, there is no direct evidence to address the issue. There are three main hypotheses for this phenomenon:
1. Antithyroid antibodies bind directly to their cognate antigens in the thyroid gland and interfere with production of thyroid hormones and hence reduce serum levels of the hormones;
2. Antithyroid antibodies are among autoantibodies that are produced during a generalized autoimmune disease with disrupted immunological balance. In fact, the presence of antithyroid antibodies can be translated as the presence of abnormal immune reactions that lead to abortion;
3. Antithyroid antibodies cross react with unknown antigenic epitope(s) in the reproductive tissue and lead to local damage and abortion (4, 7).
Despite many efforts, there is still not enough evidence to confirm or refute any one of these hypotheses. In the present study, we aimed to investigate the expression of thyroglobulin gene in murine endometrium in order to evaluate the third possibility.
Materials and Methods
In this study, white New Zealand rabbits and Balb/C mice aged 8-12 weeks were used. All procedures were conducted according to the guidelines of the animal care and ethics committee of Avicenna Research Institute.
Determination of estrous cycle
Wet vaginal smear was obtained by intra vaginal injection of Phosphate Buffered Saline (PBS). Stages of estrous cycle were determined by cellular morphology and ratio of epithelial cells to leukocytes in each slide. Five mice were studied in each four stages of estrous cycle: proestrous, estrous, metestrous and diestrous.
RNA extraction and complementary DNA (cDNA) synthesis
Following determination of estrous cycle, mice were sacrificed and their uterine horns were excised. Left uterine horn was washed completely with PBS and cut open from antimesometrial axis. Exposed endometrial tissue was then scraped with scalpel. Endometrial tissue was rapidly homogenized using pellet pestle (Sigma, USA) and dissolved in RNA-Bee (Biosite, Sweden).
As our positive control for thyroglobulin expression, thyroid gland of one mouse was excised and homogenized similarly in RNA-Bee solution. Total RNA from tissue homogenates was then extracted according to standard protocols. Briefly, after chloroform was added to and mixed with RNA-Bee solution, total RNA of tissue was collected from liquid supernatant and precipitated by 2 steps alcohol precipitation. Extracted RNA was dissolved in 20-50 [micro]l of sterile water and stored in -20[degrees]C for further analysis.
Ten micro liters of total RNA from each tissue were heated to 65[degrees]C and immediately cooled on ice. cDNA Mix including 5x buffer, 2 mM dNTP mix (Roche, Germany), 2 mM Random hexamer (Cybergene, Sweden) and 20 u/[micro]l RT M-MuLV in a final volume of 10 [micro]l distilled water was added to the RNA. The mixture was then incubated in 42[degrees]C for 60 minutes. The cDNA was then kept at -20[degrees]C.
Reverse transcriptase polymerase chain reaction (RT-PCR)
For each specimen, 3 PCR reactions were set up using 2 sets of primers for TG and 1 set for housekeeping gene GAPDH (Glycer aldehyde 3-phosphate dehydrogenase). Each PCR reaction contained 10x PCR buffer (Roche, Germany), 2.5 mM MgCl2, 0.4 mM dNTP mix and 0.04 u/[micro]l Taq DNA polymerase (all from Roche, Germany) and 0.4 [micro]M of each primer set. One microliter of cDNA mixture was added to each reaction and incubated in thermocycler with the following thermal profile: 94[degrees]C for 2 minutes for initial denaturation, 30 cycles of 94[degrees]C, 60[degrees]C and 72[degrees]C each for 30 seconds and final extension in 72[degrees]C for 6 minutes.
Sequence of the primers used is demonstrated in Table 1.
First and second sets of primers were designated to amplify 207 bp (TG1) and 510 bp (TG2) fragments of TG mRNA, respectively. The third set of primers amplified a 309 bp segment of GAPDH gene as internal control. PCR products were electrophoresed on 1% agarose gel and the amplified bands were visualized and documented by UV transilluminator (UVP, USA).
Generation of polyclonal antiTG antibody
White New Zealand rabbits were injected IM with bovine TG (Sigma, Sweden) plus freund adjuvant every 2 weeks. Before and after each injection, blood samples were collected and titers of anti TG antibody were assessed by indirect ELISA. Briefly, TG was coated on wells and after blocking, rabbit serum was added to them in serial dilutions.
Following incubation and washing, HRP conjugated sheep antirabbit antibody (Avicenna Research Institute, Iran) was added to the wells.
Finally, optical density at 450 nm was measured after addition of horseradish peroxidase (HRP) substrate, TMB (3, 3', 5, 5'-Tetra methylbenzidine).
Following the 5th injection, massive bleeding was performed and the antiTG antibody was purified over TG affinity chromatography column. Purity of the resultant antibody was assessed by electrophoresis on 10% polyacrylamide gel and its reactivity was confirmed by immunohistochemistry of mouse thyroid tissue.
Samples from uterine, ovary and fallopian tubes of 20 mice (5 mice in each phase of estrous cycle) and the thyroid from one mouse were snap frozen in OCT (Jung, Denmark). Frozen section of tissues, 5 [micro]m in thickness, were cut and transformed on glass slides. After initial steps of fixation and blocking of non-specific binding sites by 10% normal sheep serum, immunostaining was carried out by indirect method.
Briefly, slides were incubated with antiTG antibody (5 [micro]g/ml) for 90 minutes, after then endogenous peroxidase was quenched by 0.3% H2O2. 1:250 dilution of sheep antirabbit antibody (Avicenna Research Institute) was then added for 45 minutes followed by Diaminobenzidine (DAB) (Roche, Germany). Afterwards, slides were counterstained with hematoxylin, dehydrated in increasing grades of ethanol and mounted in enthelan (Merck, Germany). In negative control slides, primary antibody was substituted by the same concentration of non-immune rabbit immunoglobulin.
[FIGURE 1 OMITTED]
Amplification of TG gene by RT-PCR
As a housekeeping gene, GAPDH was used as an internal control for mRNA extraction and cDNA synthesis. As expected, 309 bp band of amplified GAPDH mRNA was found in all endometrial and thyroid samples. On the contrary, neither 207 bp nor 510 bp bands corresponding to the amplified segments of TG mRNA with TG1 & TG2 primer sets, respectively, were detected in any endometrial samples but they were both strongly positive in thyroid tissue. Therefore, we concluded that TG gene is not expressed in endometrial tissue of Balb/C mice at any stage of estrous cycle (Figure 1).
[FIGURE 2 OMMITED]
Generation and characterization of antiTG antibody
Despite the fact that we used bovine TG for immunization, the resulting polyclonal antibody had excellent reactivity with mouse TG because of high molecular homology between species. Based on ELISA assay, high titers of antiTG antibody were reached after the third round of injection.
Polyacrylamide gel electrophoresis of the purified antibody showed a dominant band of 150 kD molecular weight which corresponded to IgG isotype. In order to confirm the reactivity of the purified antibody, we used IHC staining on both frozen and paraffin embedded sections of thyroid which showed specific binding in both methods (Figure 2).
IHC staining of reproductive organs In order to study the expression of thyroglobulin at the protein level in female reproductive organs, we performed IHC staining of endometrium, ovary and fallopian tubes at different stages of estrous cycle using our homemade antiTG antibody.
As shown in Figure 3, none of the tissues of reproductive organs had detectable levels of TG, while sections of thyroid were all strongly positive for expression of TG. IHC staining confirmed our RT-PCR results and proved that TG is expressed at neither RNA nor protein level in any reproductive organs of cycling Balb/C mice.
Autoimmune thyroid disease is one of the disorders that has a known role in recurrent abortion and infertility (3). Even in the absence of clinical manifestations of thyroid dysfunction, many cases have high titers of antithyroid antibodies in their serum. Although dysfunctional production of thyroid hormones can directly cause abortion, it does not fully explain the correlation between abortion and thyroid autoimmunity. It has been well documented that cases with completely normal serum levels of thyroid hormones, but with high levels of antiTG antibodies have increased risk of abortion by at least two fold compared to normal women (14).
[FIGURE 3 OMITTED]
This increased risk could as well be explained by direct binding of thyroid autoantibodies to reproductive organs or to fetal tissues (7,15). In order to test this hypothesis, we studied the expression of TG at both mRNA and protein levels in all reproductive organs of female Balb/C mice. Since many proteins are modulated in reproductive tract under the influence of hormonal changes (16), we also tested the possibility of expression of TG gene in different stages of estrous cycle. It was clearly demonstrated that TG gene is expressed in endometrium during none of the four stages of estrous cycle. Also, we showed that no TG or TG-cross reactive antigen exists in either endometrium, ovary or fallopian tubes. Although endometrial cells of nonpregnant uterus are the same cells that comprise pregnant one, their pattern of gene expression undergoes dramatic changes during pregnancy (16). It could then be plausible that some genes, such as TG, have temporary expression only during pregnancy and therefore, study of their expression in non-pregnant state might not completely reflect the whole profile of these cells. In line with this hypothesis, it has been shown that pregnancy rate of women with antithyroid antibody was the same as normal controls but they experienced high rates of abortion afterwards (7,17). It could be implicated that TG or cross reactive antigen(s) are expressed at the interface of mother and fetus and this results in their interaction with maternal antiTG antibodies. Subsequent inflammation at the site of pregnancy then ends up in abortion. Other studies show that active immunization of pregnant mice with TG resulted in lower weight of fetus and placenta. In the same study, it was shown that maternal antiTG antibodies were able to cross placenta and enter amniotic fluid and bind directly to syncytio- and cytotrophoblasts but not to fetus (17). Transient expression of TG in decidua, placenta and fetal tissues during pregnancy is the subject of the future studies.
Received: 22 Feb 2009
Accepted: 21 April 2009
(1.) Regan L, Rai R. Epidemiology and the medical cause of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14(5):839-854.
(2.) Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: etiology, management and prognosis. Hum Reprod Update 2002;8(5): 463-481.
(3.) Matalon ST, Blank M, Levy Y, Carp HJ, Arad A, Burek L, et al. The pathogenic role of antithyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Hum Reprod 2003;18(5):1094-1099.
(4.) Kutteh WH, Yetman DL, Carr AC, Beck LA, Scott RT. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 1999;71(5):843-848.
(5.) Tincani A, Rebaioli CB, Frassi M, Taglietti M, Gorla R, Cavazzana I, et al. Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. Auto Immun Rev 2005;4(7):423-428.
(6.) Hatasaka HH, Branch DW, Kutteh WH, Scott JR. Autoantibody screening for infertility: explaining the unexplained? J Reprod Immunol 1997;34(2): 137-153.
(7.) Stagnaro-Green A, Glinoer D. Thyroid autoimmunity and the risk of miscarriage. Best Pract Res Clin Endocrinol Metab 2004;18(2):167-181.
(8.) Krassas GE. Thyroid disease and female reproduction. Fertil Steril 2000;74(6):1063-1070.
(9.) Poppe K, Velkeniers B. Female infertility and the thyroid. Best Pract Res Clin Endocrinol Metab 2004;18(2):153-165.
(10.) Poppe K, Glinoer D. Thyroid autoimmunity and hypothyroidism before and during pregnancy. Hum Reprod 2003;9(2):149-161.
(11.) Marai I, Carp H, Shai S, Shabo R, Fishman G, Shoenfeld Y. Autoantibody panel screening in recurrent miscarriages. Am J Reprod Immunol 2004;51(3):235-240.
(12.) Lockshin MD. Autoimmunity, infertility and assisted reproductive technologies. Lupus 2004;13 (9):669-672.
(13.) Pop VJ, de Vries E, van Baar AL, Waelkens JJ, de Rooy HA, Horsten M, et al. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development? J Clin Endocrinol Metab 1995;80(12):3561-3566.
(14.) Sherer Y, Tartakover-Matalon S, Blank M, Matsura E, Shoenfeldlt Y. Multiple autoantibodies associated with autoimmune reproductive failure. J Assist Reprod Genet 2003;20(2):53-57.
(15.) Shoenfeld Y, Carp HJ, Molina V, Blank M, Cervera R, Balasch J, et al. Autoantibodies and prediction of reproductive failure. Am J Reprod Immunol 2006;56(5-6):337-344.
(16.) King AE, Critchley HO, Kelly RW. Innate immune defenses in the human endometrium. Reprod Biol Endocrinol 2003;1:116.
(17.) Imaizumi M, Pritsker A, Kita M, Ahmad L, Unger P, Davies T. Pregnancy and murine thyroiditis: thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies. Endocrinology 2001;142(2):823-829.
Ali Moravvej , Mahmood Jeddi-Tehrani , Ali Reza Salek Moghaddam , Pouneh Dokouhaki , Mahdi Shekarabi , Roya Ghods , Mahdi Shahbazi , Jamileh Ghasemi , Parivash Danesh , Ahmad Reza Mahmoudi , and Amir Hassan Zarnani [3,4] *
[1.] Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
[2.] Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
[3.] Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
[4.] Immunology Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
* Corresponding author:
Amir Hassan Zarnani, Ph.D., Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran, P.O. Box: 19615-1177
Tel: +98 21 22432020
Fax: +98 21 22432021
Table 1. Sequence and amplicon size of the primers used in this study Amplicon (size) Primer Sequence TG1 (207bp) [F.sub.1] CTTTCAGCAAGACCCATTGTGTC [R.sub.1] TGTCAAATTTCCGTATCATCAGA TG2 (510bp) [F.sub.2] TTGCCTGCGTGACTTCTGACCAG [R.sub.2] CTTCCAAGAGTGCCAGACCCTG GAPDH (309bp) [F.sub.3] CAGGAGCGAGACCCCACTA [R.sub.3] GGCATGGACTGTGGTCATGA
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Original Article|
|Author:||Moravvej, Ali; Jeddi-Tehrani, Mahmood; Moghaddam, Ali Reza Salek; Dokouhaki, Pouneh; Shekarabi, Mahd|
|Publication:||Avicenna Journal of Medical Biotechnology (AJMB)|
|Date:||Apr 1, 2009|
|Previous Article:||Construction of a high efficiency PCR products cloning T vector using pgem-5zf (+).|
|Next Article:||Production and purification of streptokinase by protected affinity chromatography.|